VistaGen Therapeutics

VTGN stock is nicht Shariah-konform

Last updated:

About VistaGen Therapeutics (VTGN)

VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing medicines for anxiety, depression, and other central nervous system disorders. Its lead product candidate, PH94B, is a rapid-onset nasal spray in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. The company's pipeline also includes PH10, a rapid-onset nasal spray being prepared for Phase 2B development for major depressive disorder, and AV-101, an oral treatment being developed for levodopa-induced dyskinesia, major depressive disorder, neuropathic pain, and suicidal ideation.

Häufig gestellte Fragen

Is VistaGen Therapeutics (VTGN) stock halal to invest in?
As of , VTGN is nicht Shariah-konform and therefore considered halal to invest in. This assessment is based on the data available in VistaGen Therapeutics's most recent financial reports.
As of , VTGN is nicht Shariah-konform and therefore not considered halal to invest in. This assessment is based on the data available in VistaGen Therapeutics's most recent financial reports.
As of , VTGN is flagged as nicht Shariah-konform in terms of Shariah compliance based on the company's latest financial reports. This means that while the company's operations do not definitively violate Islamic guidelines, there are certain aspects of VistaGen Therapeutics's business that require careful consideration.
Does VistaGen Therapeutics have any interest income?
Yes, VistaGen Therapeutics does have interest income. According to the company's latest annual report for the fiscal year ending Mar 31, 2026, VistaGen Therapeutics reported revenue of $1,269,000 and interest income of $2,441,000. The interest income represents 192.36% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, VistaGen Therapeutics has not reported any interest income. According to the company's latest annual report for the fiscal year ending Mar 31, 2026, VistaGen Therapeutics reported total revenue of 1269000, with no separate interest income disclosed. However, it's worth noting that some companies may report interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if VistaGen Therapeutics stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions (AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes standards for Islamic finance. Their guidelines help determine if a company's business activities and financial structure align with Islamic principles. These standards are widely respected in the Islamic finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is VistaGen Therapeutics stock reviewed for Shariah compliance?
The Shariah compliance status of VistaGen Therapeutics stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on VistaGen Therapeutics's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of VTGN, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from VistaGen Therapeutics stock considered halal?
Yes, dividends from VTGN are considered halal. However, you may need to purify a portion of the dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of impermissible revenue for VistaGen Therapeutics (VTGN), check the Zoya app. For more details on the purification process, read our comprehensive guide.
No, dividends from VTGN are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my VistaGen Therapeutics shares?
If you hold VistaGen Therapeutics stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculator for stocks. For a more seamless experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

How to buy VistaGen Therapeutics (VTGN) stock on Zoya

  1. Kostenloses Zoya-Konto erstellen
    Der Einstieg ist ganz einfach. Sie können sich direkt auf unserer Website registrieren oder die Zoya-App für iOS oder Android herunterladen.
  2. Depot verknüpfen
    Zoya arbeitet mit führenden Brokern wie Alpaca und anderen zusammen, damit Sie Aktien nahtlos über Zoya kaufen und verwalten können.
  3. Anlagebetrag festlegen
    Öffnen Sie die Suche und geben Sie den Namen der Aktie in die Suchleiste ein. Klicken Sie anschließend auf die Schaltfläche „Kaufen“ und geben Sie den Betrag ein, den Sie investieren möchten – entweder in Dollar oder als Anzahl der Anteile. Prüfen Sie den aktuellen Aktienkurs und die geschätzte Anzahl der Anteile, bevor Sie Ihre Investition bestätigen.
  4. Ihr Portfolio an einem Ort verwalten
    Ihre neu gekaufte Aktie finden Sie zusammen mit Ihren übrigen Positionen in Ihrem Zoya-Portfolio. Aktivieren Sie Benachrichtigungen, um über Änderungen der Shariah-Konformität Ihres Portfolios informiert zu werden.

Community posts

Shariah compliance data powered by the Zoya API. Chart by TradingView